(1S,4R)-4-[(2,5-Diamino-6-chloro-4-pyrimidinyl)amino]-2-cyclopentene-1-methanol

(1S,4R)-4-[(2,5-Diamino-6-chloro-4-pyrimidinyl)amino]-2-cyclopentene-1-methanol, also known as Daraprim, is a medication used in the treatment of malaria and certain types of parasitic infections. This medication works by inhibiting the synthesis of tetrahydrofolic acid, an important component required for the survival of the parasite. The chemical structure of Daraprim consists of a cyclopentene ring attached to a pyrimidine ring with two amino groups and a hydroxyl group. Daraprim is administered orally and is rapidly absorbed in the gastrointestinal tract. The medication is metabolized in the liver and excreted through the kidneys. The dosage and duration of treatment may vary depending on the severity of the infection and the patient's response to the medication. Daraprim is often used in combination with other medications to increase its effectiveness.